BSX vs EMAT · P/E 20, rev $10.65B vs rev $3.5M
Boston Scientific Corp (BSX) versus Evolution Metals & Technologies Corp. Common Stock (EMAT) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Evolution Metals & Technologies Corp. Common Stock (EMAT) is a other industrial metals & mining company listed on NASDAQ.
Latest reported BSX revenue for 2026-06-30 was $10.65B. Net income was $2.24B. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported EMAT revenue for 2026-06-30 was $3.5M. Net income was -$452.2M. Revenue was up 87.1% from 2026-03-31 to 2026-06-30. EMAT currently screens at market cap $4.30B.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. EMAT currently screens at market cap $4.30B.
Not investment advice. Open the BSX and EMAT stock pages for the full models.
Not investment advice.